Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Hess

Showing results (151-160 of 217) with videos related to

Pageof 22
Sort By:
JCO Precision Oncology|May 7, 2019
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary MelanomasLawrence N Kwong, Mariana Petaccia De Macedo, Lauren Haydu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2005
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancerRoman Rouzier, Radhika Rajan, Peter Wagner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Oncology|December 6, 2003
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survivalVinay K Puduvalli, Masood Hashmi, Leslie D McAllister, et al.
Oncotarget|February 9, 2013
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trialsIshwaria M Subbiah, Vivek Subbiah, Apostolia M Tsimberidou, et al.
Breast Cancer Research : BCR|June 25, 2011
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatmentMario Giuliano, Antonio Giordano, Summer Jackson, et al.
Molecular Cancer|September 30, 2011
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartmentYuanjie Hu, Peter Dion Pioli, Eric Siegel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Phase I study of recombinant human endostatin in patients with advanced solid tumorsRoy S Herbst, Kenneth R Hess, Hai T Tran, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2015
Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional TreatmentSimona F Shaitelman, Welela Tereffe, Basak E Dogan, et al.
Breast Cancer Research : BCR|January 13, 2010
Effect of training-sample size and classification difficulty on the accuracy of genomic predictorsVlad Popovici, Weijie Chen, Brandon G Gallas, et al.
Pageof 22

Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
JCO Precision Oncology|May 7, 2019
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary MelanomasLawrence N Kwong, Mariana Petaccia De Macedo, Lauren Haydu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2005
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancerRoman Rouzier, Radhika Rajan, Peter Wagner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Oncology|December 6, 2003
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survivalVinay K Puduvalli, Masood Hashmi, Leslie D McAllister, et al.
Oncotarget|February 9, 2013
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trialsIshwaria M Subbiah, Vivek Subbiah, Apostolia M Tsimberidou, et al.
Breast Cancer Research : BCR|June 25, 2011
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatmentMario Giuliano, Antonio Giordano, Summer Jackson, et al.
Molecular Cancer|September 30, 2011
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartmentYuanjie Hu, Peter Dion Pioli, Eric Siegel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Phase I study of recombinant human endostatin in patients with advanced solid tumorsRoy S Herbst, Kenneth R Hess, Hai T Tran, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2015
Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional TreatmentSimona F Shaitelman, Welela Tereffe, Basak E Dogan, et al.
Breast Cancer Research : BCR|January 13, 2010
Effect of training-sample size and classification difficulty on the accuracy of genomic predictorsVlad Popovici, Weijie Chen, Brandon G Gallas, et al.
Pageof 22